Co-Diagnostics, Inc.
Income Statement
| Line Item | FY2017 |
|---|---|
| Revenue | $7.7K |
| Cost of Revenue | $302 |
| Gross Profit | $7.4K |
| Gross Margin | 96.1% |
| Operating Expenses | |
| Research & Development | $1.0M |
| SG&A Expense | $3.1M |
| Operating Income | $-4.6M |
| Operating Margin | -59,567.6% |
| Interest Expense | $310.2K |
| Pretax Income | $-7.0M |
| Income Tax Expense | — |
| Net Income | $-7.0M |
| Net Margin | -90,827.9% |
| EPS (Basic) | $-0.63 |
| EPS (Diluted) | $-0.63 |
| Shares Outstanding (Basic) | 12.3M |
| Shares Outstanding (Diluted) | 12.3M |
| Dividends Per Share | — |